HIGH FIDELITY REVERSE TRANSCRIPTASES AND USES THEREOF

Patent №

US 7,056,716

Granted

2006-06-06

Filed 2001

Owner

INVITROGEN CORPORATION

Lab

AI components

1

nlp

Assignment

Recorded

Dataset

AIPD

2023_r1 edition

Application

09808124

The invention relates to reverse transcriptases which have increased fidelity (or reduced misincorporation rate) and/or terminal deoxynucleotidyl transferase activity. In particular, the invention relates to a method of making such reverse transcriptases by modifying or mutating specified positions in the reverse transcriptases. The invention also relates to nucleic acid molecules containing the genes encoding the reverse trancriptases of the invention, to host cells containing such nucleic acid molecules and to methods to make the reverse trancriptases using the host cells. The reverse transcriptases of the invention are particularly suited for nucleic acid synthesis, sequencing, amplification and cDNA synthesis.

Natural languageC12N 9/1276C12Q 2521/107

AI classification

Natural language0.64
AI hardware0.00
Knowledge representation0.00
Vision0.00
Evolutionary computation0.00
Machine learning0.00
Planning0.00
Speech0.00

Ownership

INVITROGEN CORPORATION

assignment · 116130363

Assignors

POTTER, ROBERT JASON

On an employer assignment, the assignors are typically the inventors.

© 2026 NYSGPT2525 LLC